$2.51+5.46%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Indaptus Therapeutics last closed at $2.51 (+5.46%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -18.9×. Its overall grade ranks 129 of 741 stocks in Healthcare.
About this company
Indaptus Therapeutics last closed at $2.51 (+5.46%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A · 129/741
Valuation grade A+
Related stocks
- AstraZenecaCompetitor
면역항암·종양 치료제 개발에서 경쟁하는 대형 제약사
- Merck & Co.Competitor
항암제 포트폴리오와 면역항암 영역에서 경쟁하는 글로벌 제약사
- Bristol-Myers SquibbCompetitor
면역치료·종양학 분야에서 경쟁하는 대형 바이오파마
About Indaptus Therapeutics
- What technical signals does Indaptus Therapeutics (INDP) have?
- Indaptus Therapeutics current technical signals: no active technical signal.
- Is Indaptus Therapeutics a cup-and-handle pattern?
- No. Indaptus Therapeutics has no valid Cup signal right now.
- What published figures are available for Indaptus Therapeutics?
- Market cap: $4.4M. Trailing 12 months PER: -18.9×. Latest quarter PBR: 25.63×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Indaptus Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy